Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment

a technology of glucocorticosteroid and dosage form, which is applied in the direction of pharmaceutical product form change, inorganic non-active ingredients, drug compositions, etc., can solve the problems of osteoarthritis, affecting the treatment effect, and most likely to suffer heart attack or stroke, so as to reduce the risk of disease, less medication, and more efficient treatment

Inactive Publication Date: 2003-10-09
PENWEST PHARMA CO
View PDF15 Cites 27 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0008] It is a further object of the present invention to provide an oral pharmaceutical dosage form that provides a delayed release of a steroidal drug(s) into the gastrointestinal tract of a patient at a predetermined time after oral ingestion of the dosage form.
[0122] The benefits of chronotherapeutics include safety and more efficient treatment than conventional therapies. This is achieved by delivering more medication when risk of disease is greater, and delivering less medication when potential for disease symptoms are less likely. Other benefits to the patient include an increased quality of life and a once-a-day drug delivery system to increase patient compliance.

Problems solved by technology

When one wakes up, hay fever is at its most tormenting, and in the morning hours, as ones blood pressure rises to meet the day, one is most likely to suffer a heart attack or stroke.
Rheumatoid arthritis improves through the day, but osteoarthritis grows worse.
This disintegration would typically have a detrimental effect upon the sustained release of the active agent.
Such coated pharmaceutical formulations, in addition to slowing the release rate of the active agent contained within the core of the tablet, can also effectuate a delay in the release of the active ingredient for a desired period of time such that the dissolution of the active drug core can be delayed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment
  • Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment
  • Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment

Examples

Experimental program
Comparison scheme
Effect test

example 2

[0132] A delayed release material to be used in the compression coatings of the invention is prepared having the following formulation listed in Table 2:

3 TABLE 2 Component Percentage 1. Xanthan Gum 25 2. Locust Bean Gum 25 3. Dextrose 35 4. Calcium Sulfate Dihydrate 10 5. Ethylcellulose 5 5. Alcohol, SD3A, anhydrous* 20 6. Water* q.s. *Removed during processing

[0133] Process:

[0134] 1. The requisite amounts of xanthan gum, locust bean gum, calcium sulfate, and dextrose are dry blended in a high speed mixer / granulator for 3 minutes.

[0135] 2. A slurry of hydrophobic polymer (ethylcellulose) is prepared by dissolving ethyl cellulose in ethyl alcohol.

[0136] 3. The slurry is added to the dry blended mixture, and granulated for another 3 minutes.

[0137] 4. The granulation was then dried in a fluid bed dryer to a LOD (loss on drying) of less than about 10% by weight (e.g., 4-7% LOD).

[0138] 5.

example 3

[0139] A delayed release material to be used in the compression coatings of the invention is prepared having the following formulation listed in Table 3:

4 TABLE 3 Component Percentage 1. Xanthan Gum 15 2. Locust Bean Gum 15 3. Dextrose 60 4. Calcium Sulfate Dihydrate 10 5. Water* q.s. *Removed during processing

[0140] Process:

[0141] 1. The requisite amounts of xanthan gum, locust bean gum, calcium sulfate, and dextrose are dry blended in a high speed mixer / granulator for 3 minutes.

[0142] 2. Water (125-150 ml) is added to the dry blended mixture, and granulated for another 3 minutes.

[0143] 3. The granulation is then dried in a fluid bed dryer to a LOD (loss on drying) of less than abou-t 10% by weight (e.g., 4-7% LOD).

example 4

[0144] A delayed release material to be used in the compression coatings of the invention is prepared having the following formulation listed in Table 4:

5 TABLE 4 Component Percentage 1. Xanthan Gum 16 2. Locust Bean Gum 24 3. Dextrose 60 4. Water* q.s. *Removed during processing

[0145] Process:

[0146] The same process for Example 1 is used to prepare the delayed release coating of Example 4.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
timeaaaaaaaaaa
time periodaaaaaaaaaa
Login to View More

Abstract

A chronotherapeutic pharmaceutical formulation comprising a core containing an active agent (e.g., a drug) and a delayed release compression coating comprising a natural or synthetic gum applied onto the surface of the core.

Description

[0001] This application claims priority from U.S. Provisional Application No. 60 / 275,382, filed Mar., 31, 2001, the disclosure of which is hereby incorporated by reference in its entirety.[0002] The present invention relates to a chronotherapeutic dosage form containing a therapeutically effective amount of a drug. The present invention is further related to methods of preparing such formulations, and to methods of treatment utilizing such formulations.[0003] Coordinating biological rhythms (chronobiology) with medical treatment is called chronotherapy. Chronotherapy takes into consideration a person's biological rhythms in determining the timing--and sometimes the amount--of medication to optimize desired effects of a drug(s) and minimize the undesired effects. The synchronization of medication levels to the biological rhythms of disease activity is playing an increasing role in the management of common cardiovascular conditions such as hypertension, elevated cholesterol, angina, s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/20A61K9/22A61J3/06A61K9/26A61K9/28A61K9/30A61K9/32A61K9/34A61K9/36A61K31/573A61K47/02A61K47/04A61K47/10A61K47/12A61K47/26A61K47/30A61K47/32A61K47/36A61K47/38A61K47/44A61K47/46A61M37/00A61P5/00A61P9/10A61P9/12A61P11/08A61P19/02
CPCA61K9/2009A61K9/2054A61K9/2813A61K31/573A61K9/286A61K9/2866A61K9/2826A61P11/08A61P19/02A61P5/00A61P9/10A61P9/12A61K9/20
Inventor BAICHWAL, ANAND R.WOODCOCK, PAULHIGGINS, RAYMONDCOBB, JACLYN
Owner PENWEST PHARMA CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products